Have you just been diagnosed with Type 1 Diabetes?

T1D-SGLT2 study to preserve pancreas function in type 1 diabetes

This study aims to determine the safety and feasibility of a tablet called empagliflozin to treat type 1 diabetes soon after it is diagnosed.

Anticipated date enrolment will close: June 2018

Who can take part

  • Diagnosed with type 1 diabetes within the last 100 days

  • Age between 18 and 40

What is involved for you

  • 13 visits over 9 months
  • 4 pancreas function tests wherein blood samples are collected before and after a liquid meal
  • 4 periods wherein a continuous glucose monitor is worn for 5 days
check
Observational
Phase 1
Phase 2
Phase 3
Phase 4

For more information

Quote reference number
2016.367
John Wentworth
03 93427855